MacroGenics
MGNX
#9449
Rank
โ‚น11.64 B
Marketcap
โ‚น182.19
Share price
-0.71%
Change (1 day)
45.00%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น49.67

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น52.82. In 2025 the company made an earnings per share (EPS) of -โ‚น109.35 a decrease over its 2024 EPS that were of -โ‚น99.16.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น49.67-54.58%
2025-โ‚น109.3510.28%
2024-โ‚น99.16613.33%
2023-โ‚น13.90-92.31%
2022-โ‚น180.71-42.14%
2021-โ‚น312.3036.44%
2020-โ‚น228.89-21.84%
2019-โ‚น292.84-24.58%
2018-โ‚น388.29675.93%
2017-โ‚น50.04-68.05%
2016-โ‚น156.61168.25%
2015-โ‚น58.38-55%
2014-โ‚น129.743400%
2013-โ‚น3.71-108.68%
2012โ‚น42.7224.49%
2011โ‚น34.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.80-224.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,863-5,519.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,611-3,149.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น287.28 443.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.87-892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น145.49 175.44%๐Ÿ‡บ๐Ÿ‡ธ USA